ThirtyFiveBio
Stuart Hughes is currently the CEO of Pathios Therapeutics and the Co-founder of ThirtyFiveBio. Prior to their current roles, Stuart held various positions at Vertex Pharmaceuticals and Eli Lilly. With a background in neuroscience and electrical & electronic engineering, Stuart's career includes research and academic roles at Cardiff University, as well as experience in the pharmaceutical and systems analysis industries.
This person is not in the org chart